Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Oral Sci ; 123(4): 235-41, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26010823

RESUMO

The aim was to investigate how endogenous cytokine control of tumor necrosis factor (TNF) influences temporomandibular joint (TMJ) pain in relation to the role of anti-citrullinated peptide antibodies (ACPA) in patients with rheumatoid arthritis (RA). Twenty-six consecutive patients with TMJ RA were included. Temporomandibular joint pain intensity was assessed at rest, on maximum mouth opening, on chewing, and on palpation. Mandibular movement capacity and degree of anterior open bite (a clinical sign of structural destruction of TMJ tissues) were also assessed. Systemic inflammatory activity was assessed using the Disease Activity Score in 28 joints (DAS28) for rheumatoid arthritis. Samples of TMJ synovial fluid and blood were obtained and analyzed for TNF, its soluble receptor, soluble TNF receptor II (TNFsRII), and ACPA. A high concentration of TNF in relation to the concentration of TNFsRII in TMJ synovial fluid was associated with TMJ pain on posterior palpation on maximum mouth opening. The ACPA concentration correlated significantly to the TNF concentration, but not to the TNFsRII concentration, indicating that increased inflammatory activity is mainly caused by an insufficient increase in anti-inflammatory mediators. This study indicates that TMJ pain on palpation in patients with RA is related to a deficiency in local cytokine control that contributes to increased inflammatory activity, including sensitization to mechanical stimuli over the TMJ.


Assuntos
Artrite Reumatoide/imunologia , Interleucina-1beta/imunologia , Transtornos da Articulação Temporomandibular/imunologia , Fator de Necrose Tumoral alfa/imunologia , Adulto , Autoanticorpos/análise , Autoanticorpos/sangue , Sedimentação Sanguínea , Proteína C-Reativa/análise , Feminino , Humanos , Proteína Antagonista do Receptor de Interleucina 1/análise , Proteína Antagonista do Receptor de Interleucina 1/sangue , Interleucina-1beta/análise , Interleucina-1beta/sangue , Masculino , Mastigação/fisiologia , Pessoa de Meia-Idade , Mordida Aberta/classificação , Medição da Dor/métodos , Palpação , Peptídeos Cíclicos/análise , Peptídeos Cíclicos/sangue , Amplitude de Movimento Articular/fisiologia , Receptores Tipo I de Interleucina-1/análise , Receptores Tipo I de Interleucina-1/sangue , Receptores Tipo II de Interleucina-1/análise , Receptores Tipo II de Interleucina-1/sangue , Receptores Tipo II do Fator de Necrose Tumoral/análise , Receptores Tipo II do Fator de Necrose Tumoral/sangue , Fator Reumatoide/análise , Fator Reumatoide/sangue , Líquido Sinovial/química , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA